Structural highlights
4il5 is a 2 chain structure with sequence from Enthi. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
|
| Ligands: | , |
| NonStd Res: | |
| Related: | 2pqm, 3bm5, 4jbl, 4jbn |
| Gene: | EhOASS (ENTHI) |
| Activity: | Cysteine synthase, with EC number 2.5.1.47 |
| Resources: | FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT |
Publication Abstract from PubMed
BACKGROUND: O-acetyl serine sulfhydrylase (OASS) is a pyridoxal phosphate (PLP) dependent enzyme catalyzing the last step of the cysteine biosynthetic pathway. Here we analyze and investigate the factors responsible for recognition and different conformational changes accompanying the binding of various ligands to OASS. METHODS: X ray crystallography was used to determine the structures of OASS from Entamoeba histolytica in complex with methionine (substrate analog), isoleucine (inhibitor) and an inhibitory tetra-peptide to 2.00A, 2.03A and 1.87A resolutions, respectively. Molecular dynamics simulations were used to investigate the reasons responsible for the extent of domain movement and cleft closure of the enzyme in presence of different ligands. RESULTS: Here we report for the first time an OASS-methionine structure with an unmutated catalytic lysine at the active site. This is also the first OASS structure with a closed active site lacking external aldimine formation. The OASS-isoleucine structure shows the active site cleft in open state. Molecular dynamics studies indicate that cofactor PLP, N88 and G192 form a triad of energy contributors to close the active site upon ligand binding and orientation of the Schiff base forming nitrogen of the ligand is critical for this interaction. CONCLUSIONS: Methionine proves to be a better binder to OASS than isoleucine. The beta branching of isoleucine does not allow it to reorient itself in suitable conformation near PLP to cause active site closure. GENERAL SIGNIFICANCE: Our findings have important implications in designing better inhibitors against OASS across all pathogenic microbial species.
Molecular basis of ligand recognition by OASS from E. histolytica: insights from structural and molecular dynamics simulation studies.,Raj I, Mazumder M, Gourinath S Biochim Biophys Acta. 2013 Oct;1830(10):4573-83. doi:, 10.1016/j.bbagen.2013.05.041. Epub 2013 Jun 6. PMID:23747298[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Raj I, Mazumder M, Gourinath S. Molecular basis of ligand recognition by OASS from E. histolytica: insights from structural and molecular dynamics simulation studies. Biochim Biophys Acta. 2013 Oct;1830(10):4573-83. doi:, 10.1016/j.bbagen.2013.05.041. Epub 2013 Jun 6. PMID:23747298 doi:http://dx.doi.org/10.1016/j.bbagen.2013.05.041
